CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Post-COVID data show that circulatory claims have increased by nearly 60%, while neoplasms remain the leading source of ...

A recent White House executive order could make it harder for millions of Americans to access their lifesaving medications.

Its causes are too numerous to list. It can cripple a person’s body, state of mind, bank account, quality of life, and job ...

Patients with CSU have a higher burden than patients with CIndU, including on quality of life, economic effect, and knowledge about treatment.

Health-care companies rose as deal activity offset more health-insurance controversy. Merck struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive ...

Minister of Health and Wellness Dr. Michael Darville said yesterday that a bill that would integrate the prescription drug ...